SCHEDULE 13G: Investment Firms Disclose 6.2% Stake in Aptevo Therapeutics
Beneficial Ownership Report (Schedule 13G)
CVI Investments, Inc. and Heights Capital Management, Inc. have jointly disclosed a 6.2% beneficial ownership stake in Aptevo Therapeutics Inc. through a Schedule 13G filing.
Summary
- CVI Investments, Inc. and Heights Capital Management, Inc. (collectively, "Reporting Persons") have filed a Schedule 13G with the U.S. Securities and Exchange Commission (SEC).
- The filing discloses their beneficial ownership of 200,000 shares of common stock in Aptevo Therapeutics Inc. (CUSIP: 03835L405).
- This ownership represents 6.2% of Aptevo Therapeutics Inc.'s outstanding common stock, based on 3,223,214 shares outstanding as of the completion of an offering referenced in a Prospectus Supplement filed on April 4, 2025.
- Heights Capital Management, Inc. serves as the investment manager for CVI Investments, Inc. and exercises shared voting and dispositive power over these shares.
- The filing certifies that the shares were not acquired or held for the purpose of changing or influencing the control of Aptevo Therapeutics Inc.
Sentiment
Score: 5
Explanation: The document is a factual, regulatory disclosure of beneficial ownership, carrying a neutral sentiment. It indicates a significant investment by an institutional entity, which can be mildly positive, but the filing itself is purely informational.
Positives
- A significant institutional investor, CVI Investments, Inc., holds a 6.2% stake in Aptevo Therapeutics Inc., managed by Heights Capital Management, Inc., indicating a notable investment position.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of beneficial ownership by institutional investors in a publicly traded company. It reflects an investment position rather than a strategic industry move or competitive analysis.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Delegation of Authority | CVI Investments, Inc. granted a Limited Power of Attorney to Heights Capital Management, Inc. on July 16, 2015, authorizing Heights Capital to enter into transactions and manage investments on CVI's behalf. | 2015-07-16 | This formalizes the investment management relationship, allowing Heights Capital Management, Inc. to execute trades and related actions for CVI Investments, Inc. without requiring individual approvals for each transaction. |
Stakeholder Impact
- Shareholders: Increased transparency regarding significant institutional ownership.
- Investment Community: Provides insight into institutional investment activity in Aptevo Therapeutics Inc.
Key Dates
| Date | Description |
|---|---|
| 2015-07-16 | Date of Limited Power of Attorney agreement between CVI Investments, Inc. and Heights Capital Management, Inc. |
| 2025-02-14 | Date of Aptevo Therapeutics Inc.'s Prospectus. |
| 2025-04-03 | Date of event which required the filing of the Schedule 13G (triggering event for ownership disclosure). |
| 2025-04-04 | Date of filing of Aptevo Therapeutics Inc.'s Prospectus Supplement, indicating 3,223,214 shares outstanding. |
| 2025-04-10 | Date of signing of the Schedule 13G and Joint Filing Agreement by Brian Sopinsky. |
Keywords
Aptevo Therapeutics Inc., CVI Investments Inc., Heights Capital Management Inc., Schedule 13G, Beneficial Ownership, Common Stock, Investment Management, SEC Filing, Institutional Investor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.